|

LY4337713 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Eli Lilly and Company1

Indications

  • Pancreatic Intraductal Neoplasms1
  • Esophageal Neoplasms1
  • Ovarian Neoplasms1
  • Cholangiocarcinoma1
  • Stomach Neoplasms1

Newport Beach, California1 trial

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Hoag Memorial Hospital Presbyterian

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.